BAFF, APRIL, TWE-PRIL: Who's who? (Q21564037)

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

BLyS--an essential survival factor for B cells: basic biology, links to pathology and therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

The crystal structure of a proliferation-inducing ligand, APRIL.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

TWE-PRIL; a fusion protein of TWEAK and APRIL

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

The molecular architecture of the TNF superfamily

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

Structural basis of BLyS receptor recognition

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

Identification of proteoglycans as the APRIL-specific binding partners.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

Characterization of a new member of the TNF family expressed on antigen presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021

BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2007.05.002

7 January 2021